Inventor · disambiguated record
Assaf Lask
Also filed as: LASK ASSAF
6 granted patents·4 pending applications·21 citations·filing 2011–2023
78Inventor score
Top patents by PatentIndex Score
10 records- 0191US12391916B2Veto cells generated from memory T cellsYEDA RES & DEV·Filed 2023·Granted Aug 19, 2025·1 cites·27 claims
- 0291US10961504B2Veto cells generated from memory T cellsYEDA RES & DEV·Filed 2017·Granted Mar 30, 2021·6 cites·37 claims
- 0389US9421228B2Use of anti third party central memory T cells for anti-leukemia/lymphoma treatmentREISNER YAIR·Filed 2011·Granted Aug 23, 2016·12 cites·19 claims
- 0486US11773372B2Veto cells generated from memory T cellsYEDA RES & DEV·Filed 2021·Granted Oct 3, 2023·1 cites·21 claims
- 0581US11324777B2Anti third party central memory T cells, methods of producing same and use of same in transplantation and disease treatmentYEDA RES & DEV·Filed 2017·Granted May 10, 2022·1 cites·18 claims
- 0675US12133866B2Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatmentYEDA RES & DEV·Filed 2022·Granted Nov 5, 2024·0 cites·19 claims
- 0754US2023321235A1Veto car-t cellsYEDA RES & DEV·Filed 2021·Application pending·0 cites
- 0851US2023398214A1Anti-viral central memory cd8+ veto cells in haploidentical stem cell transplantationYEDA RES & DEV·Filed 2020·Application pending·0 cites
- 0951US2014212398A1Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatmentREISNER YAIR·Filed 2012·Application pending·0 cites
- 1048US2016354410A1Use of anti third party central memory t cells for anti-leukemia/lymphoma treatmentYEDA RES & DEV·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Assaf Lask files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →